Heterogeneous distribution of angiotensin I-converting enzyme (CD143) in the human and rat vascular systems: Vessel, organ and species specificity

Microvascular Research

Volumn 81, Issue 2, 2011, Pages 206-215

  Metzger, Roman ^a   Franke, Folker E ^b   Bohle, Rainer M ^c   Alhenc Gelas, François ^d   Danilov, Sergei M ^e,f  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Angiotensin I converting enzyme; Arteries; CD143; Endothelium; Heart; Kidney; Microcirculation

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; KININ;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; LUNG BLOOD VESSEL; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPECIES DIFFERENCE; TISSUE SECTION; VEIN DIAMETER;

ADULT; AGED; ANIMAL STRUCTURES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ARTERIES; BLOOD VESSELS; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LUNG; MICROSCOPY, IMMUNOELECTRON; MICROVESSELS; MIDDLE AGED; ORGAN SPECIFICITY; PEPTIDYL-DIPEPTIDASE A; POSTMORTEM CHANGES; RATS; RATS, INBRED LEW; RATS, WISTAR; SPECIES SPECIFICITY; VEINS;

RATTUS;

EID: 79651473319     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.12.003     Document Type: Article

References (58)

1. Aird W.C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 2007, 100:174-190.
2. Alhenc-Gelas F., Corvol P. Molecular and physiological aspects of angiotensin I-converting enzyme. Handbook of Physiology 2000, vol.III:81-103. American Physiological Society and Oxford University Press, New York, Section 7. J.C.S. Fray, H.M. Goodman (Eds.).
3. Arnal J.F., Battle T., Rasetti C., Challah M., Costerousse O., Vicaut E., Michel J.B., Alhenc-Gelas F. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am. J. Physiol. 1994, 267(5 Pt 2):H1777-H1784.
4. Balyasnikova I.V., Danilov S.M., Muzykantov V.R., Fisher A.B. Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In Vitro. Dev. Biol. Anim. 1998, 34:545-554.
5. Bergaya S., Meneton P., Bloch-Faure M., Mathieu E., Alhenc-Gelas F., Levy B.I., Boulanger C.M. Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ. Res. 2001, 88:593-599.
6. Bernstein K.E., Xiao H.D., Frenzel K., Li P., Shen X.Z., Adams J.W., Fuchs S. Six truisms concerning ACE and the renin-angiotensin system educed from the genetic analysis of mice. Circ. Res. 2005, 96:1135-1144.
7. Bruneval P., Hinglais N., Alhenc Gelas F., Tricottet V., Corvol P., Menard J., Camilleri J.P., Bariety J. Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry 1986, 85:73-80.
8. Caldwell P.R., Seegal B.C., Hsu K.C., Das M., Soffer R.L. Angiotensin-converting enzyme: vascular endothelial localization. Science 1976, 191:1050-1051.
9. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
10. Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., MacDonald S., Pulford K.A., Stein H., Mason D.Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 1984, 32:219-229.
11. Cushman D.W., Cheung H.S. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim. Biophys. Acta 1971, 250:261-265.
12. Cushman D.W., Ondetti M.A. Inhibitors of angiotensin-converting enzyme. Prog. Med. Chem. 1980, 17:41-104.
13. Danilov S.M., Faerman A.I., Printseva O.Y., Martynov A.V., Sakharov I.Y., Trakht I.N. Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies. Histochemistry 1987, 87:487-490.
14. Danilov S., Jaspard E., Churakova T., Towbin H., Savoie F., Wei L., Alhenc Gelas F. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site. J. Biol. Chem. 1994, 269:26806-26814.
15. Danilov S.M., Franke F.E., Erdos E.G. CD143 (angiotensin-converting enzyme) workshop panel report. Leucocyte Typing VI 1997, 746-749. Garland Publishing, Inc., New York & London. T. Kishimoto (Ed.).
16. Danser A.H., Koning M.M., Admiraal P.J., Sassen L.M., Derkx F.H., Verdouw P.D., Schalekamp M.A. Production of angiotensin I and II at tissue sites in intact pigs. Am. J. Physiol. 1992, 263:H429-H437.
17. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM- 1). J. Immunol. 1986, 137:245-254.
18. Dzau V.J., Bernstein K., Celermajer D., Cohen J., Dahlof B., Deanfield J., Diez J., Drexler H., Ferrari R., van Gilst W., Hansson L., Hornig B., Husain A., Johnston C., Lazar H., Lonn E., Luscher T., Mancini J., Mimran A., Pepine C., Rabelink T., Remme W., Ruilope L., Ruzicka M., Schunkert H., Swedberg K., Unger T., Vaughan D., Weber M. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am. J. Cardiol. 2001, 88:1L-20L. (Suppl.).
19. Erdos E.G. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990, 16:363-370.
20. Falkenhahn M., Franke F., Bohle R.M., Zhu Y.C., Stauss H.M., Bachmann S., Danilov S., Unger T. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 1995, 25:219-226.
21. Faxon D.P. for the Multicenter American Research Trial with Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) study group. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J. Am. Coll. Cardiol. 1995, 25:362-369.
22. Franke F.E., Schachenmayr W., Osborn M., Altmannsberger M. Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am. J. Pathol. 1991, 139:67-79.
23. Gerritsen M.E. Functional heterogeneity of vascular endothelial cells. Biochem. Pharmacol. 1987, 36:2701-2711.
24. Haberbosch W., Bohle R.M., Franke F.E., Danilov S., Alhenc-Gelas F., Braun-Dullaeus R., Hölschermann H., Waas W., Tillmanns H., Gardemann A. The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis 1997, 130:203-213.
25. Huang W., Gallois Y., Bouby N., Bruneval P., Heudes D., Belair M.F., Krege J.H., Meneton P., Marre M., Smithies O., Alhenc-Gelas F. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc. Natl Acad. Sci. USA 2001, 98:13330-13334.
26. Johnson A.R., Schulz W.W., Noguiera L.A., Erdos E.G. Kinins and angiotensins. Angiotensin I converting enzyme (kininase II) in endothelial cells cultured from human pulmonary arteries and veins. Clin. Exp. Hypertens. 1980, 2:659-674.
27. Krege J.H., John S.W., Langenbach L.L., Hodgin J.B., Hagaman J.R., Bachman E.S., Jennette J.C., O'Brien D.A., Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995, 375:146-148.
28. Kumar S., West D.C., Ager A. Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation 1987, 36:57-70.
29. Kuzu I., Bicknell R., Fletcher C.D., Gatter K.C., Page C., Rose M., Yacoub M., Pigott R. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Antigenic heterogeneity of vascular endothelium. Lab. Invest. 1992, 141:673-683.
30. Lascano E.F., Berria M.I. PAP labeling enhancement by osmium tetroxide-potassium ferrocyanide treatment. J. Histochem. Cytochem. 1988, 36:697-699.
31. MacGregor D.P., Murone C., Mendelsohn F.A. The stability of angiotensin receptors and angiotensin converting enzyme in post mortem brain. Neurochem. Int. 1994, 25:413-417.
32. Marre M., Bernadet P., Gallois Y., Savagner F., Guyene T.T., Hallab M., Cambien F., Passa P., Alhenc Gelas F. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994, 43:384-388.
33. Messadi E, Vincent MP, Griol-Charhbili V, Mandet C, Colucci J, Krege JH, Bruneval P, Bouby N, Smithies O, Alhenc-Gelas F, Richer C. Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB J. 2010 Dec;24(12):4691-700.
34. Metzger R., Bohle R.M., Kerkman L., Eichner G., Alhenc-Gelas F., Danilov S.M., Franke F.E. Distribution of angiotensin I-converting enzyme (CD 143) in the normal human kidney and in non-neoplastic kidney diseases. Kidney Int. 1999, 56:1442-1454.
35. Metzger R., Rolle U., Fiegel H.C., Franke F.E., Münstedt K., Till H. C-kit receptor in the human vas deferens: distinction of mast cells, interstitial cells and interepithelial cells. Reproduction 2008, 135(3):377-384.
36. Mounier F., Hinglais N., Sich M., Gros F., Lacoste M., Deris Y., Alhenc Gelas F., Gubler M.C. Ontogenesis of angiotensin-I converting enzyme in human kidney. Kidney Int. 1987, 32:684-690.
37. Muller D.N., Bohlender J., Hilgers K.F., Dragun D., Costerousse O., Menard J., Luft F.C. Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 1997, 29:98-104.
38. Myers W., Honig C. Number and distribution of capillaries as determinants of myocardial oxygen tension. Am. J. Physiol. 1964, 207:653-660.
39. Parums D.V., Cordell J.L., Micklem K., Heryet A.R., Gatter K.C., Mason D.Y. JC70 a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol. 1990, 43:752-757.
40. Powel J.S., Clozel J.P., Muller R.K., Kuhn H., Hefti F., Hosang M., Baumgartner H.R. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1998, 245(4914):186-188.
41. Remmele W., Schicketanz K.H. Immunohistochemical determination of estrogen and progesteron receptor content in human breast cancer. Computer-assisted image analysis (CAIC score) vs. subjective grading (IRS). Pathol. Res. Pract. 1993, 189:862-866.
42. Rieder M.J., Carmona R., Krieger J.E., Pritchard K.A., Greene A.S. Suppression of angiotensin-converting enzyme expression and activity by shear stress. Circ. Res. 1997, 80:312-319.
43. Risau W. Differentiation of endothelium. FASEB J. 1995, 9:926-933.
44. Rogerson F.M., Chai S.Y., Schlawe I., Murray W.K., Marley P.D., Mendelsohn F.A. Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J. Hypertens. 1992, 10:615-620.
45. Roman R.J., Kaldunski M.L., Scicli A.G., Carretero O.A. Influence of kinins and angiotensin II on the regulation of papillary blood flow. Am. J. Physiol. 1988, 255:801-804.
46. Ryan U.S., Ryan J.W., Whitaker C., Chiu A. Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell 1976, 8:125-145.
47. Sayed-Tabatabaei F.A., Oostra B.A., Isaacs A., van Duijn C.M., Witteman J.C. ACE polymorphisms. Circ. Res. 2006, 98:1123-1133.
48. Schutz S., Lemoullec J.M., Corvol P., Gasc J.M. Early expression of all the components of the renin angiotensin system in human development. Am. J. Pathol. 1996, 149:2067-2079.
49. Sibony M., Gasc J.M., Soubrier F., Alhenc Gelas F., Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 1993, 21:827-835.
50. Skeggs L.T., Kahn J.R., Shumway N.P. The preparation and function of the hypertensin converting enzyme. J. Exp. Med. 1956, 103:295-299.
51. Takada Y., Unno M., Hiwada K., Kokubu T. Immunological and immunofluorescent studies of human angiotensin-converting enzyme. Clin. Sci. 1981, 61(Suppl. 7):253s-256s.
52. Takahashi N., Hagaman J.R., Kim H.S., Smithies O. Minireview: computer simulations of blood pressure regulation by the renin-angiotensin system. Endocrinology 2003, 144:2184-2190.
53. Tang T., Connelly B.A., Joyner W.L. Heterogeneity of endothelial cell function for angiotensin conversion in serial-arranged arterioles. J. Vasc. Res. 1995, 32:129-137.
54. Topouzis S., Catravas J.D., Ryan J.W., Rosenquist T.H. Influence of vascular smooth muscle heterogeneity on angiotensin converting enzyme activity in chicken embryonic aorta and in endothelial cells in culture. Circ. Res. 1992, 71:923-931.
55. Unger T., Gohlke P. Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovasc. Res. 1994, 28:146-158.
56. Vane J.R. Sites of conversion of angiotensin I. Hypertension 1972, 523-532. Springer Verlag, Berlin. J. Genest, E. Koine (Eds.).
57. Wendelschafer-Crabb G., Erlandsen S.L., Walker D.H. Ultrastructural localization of viral antigens using the unlabeled antibody-enzyme method. J. Histochem. Cytochem. 1976, 24:517-526.
58. Yu F.S., Lee S.L., Fanburg B.L. Smooth muscle cell conditioned medium elevates angiotensin-converting enzyme of bovine pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 1989, 1:401-405.